scholarly journals Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Socratis Avgeris ◽  
Florentia Fostira ◽  
Andromachi Vagena ◽  
Yiannis Ninios ◽  
Angeliki Delimitsou ◽  
...  
2002 ◽  
Vol 15 (3) ◽  
pp. 205-210 ◽  
Author(s):  
Karen Duffy ◽  
Tahseen Al-Saleem ◽  
Magdalena Karbowniczek ◽  
David Ewalt ◽  
Amanda H Prowse ◽  
...  

Epilepsia ◽  
2021 ◽  
Vol 62 (3) ◽  
pp. 785-794
Author(s):  
Jakob Stockinger ◽  
Adam Strzelczyk ◽  
Andrea Nemecek ◽  
Michal Cicanic ◽  
Frank Bösebeck ◽  
...  

2015 ◽  
Vol 89 (15) ◽  
pp. 7625-7635 ◽  
Author(s):  
Yadan Bai ◽  
Baoqin Xuan ◽  
Haiyan Liu ◽  
Jin Zhong ◽  
Dong Yu ◽  
...  

ABSTRACTThe mammalian target of rapamycin complex 1 (mTORC1) controls cell growth and anabolic metabolism and is a critical host factor activated by human cytomegalovirus (HCMV) for successful infection. The multifunctional HCMV protein pUL38 previously has been reported to activate mTORC1 by binding to and antagonizing tuberous sclerosis complex protein 2 (TSC2) (J. N. Moorman et al., Cell Host Microbe 3:253–262, 2008,http://dx.doi.org/10.1016/j.chom.2008.03.002). pUL38 also plays a role in blocking endoplasmic reticulum stress-induced cell death during HCMV infection. In this study, we showed that a mutant pUL38 lacking the N-terminal 24 amino acids (pHA-UL3825–331) was fully functional in suppressing cell death during infection. Interestingly, pHA-UL3825–331lost the ability to interact with TSC2 but retained the ability to activate mTORC1, although to a lesser extent than full-length pHA-UL38. Recombinant virus expressing pHA-UL3825–331replicated with ∼10-fold less efficiency than the wild-type virus at a low multiplicity of infection (MOI), but it grew similarly well at a high MOI, suggesting an MOI-dependent importance of pUL38-TSC2 interaction in supporting virus propagation. Site-directed mutational analysis identified a TQ motif at amino acid residues 23 and 24 as critical for pUL38 interaction with TSC2. Importantly, when expressed in isolation, the TQ/AA substitution mutant pHA-UL38 TQ/AA was capable of activating mTORC1 just like pHA-UL3825–331. We also created TSC2-null U373-MG cell lines by CRISPR genome editing and showed that pUL38 was capable of further increasing mTORC1 activity in TSC2-null cells. Therefore, this study identified the residues important for pUL38-TSC2 interaction and demonstrated that pUL38 can activate mTORC1 in both TSC2-dependent and -independent manners.IMPORTANCEHCMV, like other viruses, depends exclusively on its host cell to propagate. Therefore, it has developed methods to protect against host stress responses and to usurp cellular processes to complete its life cycle. mTORC1 is believed to be important for virus replication, and HCMV maintains high mTORC1 activity despite the stressful cellular environment associated with infection. mTORC1 inhibitors suppressed HCMV replicationin vitroand reduced the incidence of HCMV reactivation in transplant recipients. We demonstrated that mTORC1 was activated by HCMV protein pUL38 in both TSC2-dependent and TSC2-independent manners. The pUL38-independent mode of mTORC1 activation also has been reported. These novel findings suggest the evolution of sophisticated approaches whereby HCMV activates mTORC1, indicating its importance in the biology and pathogenesis of HCMV.


2001 ◽  
Vol 25 (3) ◽  
pp. 213-216 ◽  
Author(s):  
Dominique Parain ◽  
Marie J Penniello ◽  
Patrick Berquen ◽  
Thierry Delangre ◽  
Catherine Billard ◽  
...  

1999 ◽  
Vol 44 (6) ◽  
pp. 391-396 ◽  
Author(s):  
H. Zhang ◽  
E. Nanba ◽  
T. Yamamoto ◽  
H. Ninomiya ◽  
K. Ohno ◽  
...  

Author(s):  
Shruthi Sudarshan ◽  
Atin Kumar ◽  
Arun Gupta ◽  
Neetu Bhari ◽  
Gomathy Sethuraman ◽  
...  

AbstractTuberous sclerosis complex (TSC) is a multiorgan disorder characterized by formation of hamartomas and broad phenotypic spectrum including seizures, mental retardation, renal dysfunction, skin manifestations and brain tubers. It is inherited in an autosomal dominant pattern, caused due to mutation in either TSC1 or TSC2 genes. Seizures are one of the major presenting symptoms of TSC that helps in early diagnosis. The present study describes the mutation spectrum in TSC1 and TSC2 genes in TSC patients and their association with neurocognitive-behavioral phenotypes. Ninety-eight TSC patients were enrolled for TSC genetic testing after detailed clinical and neurobehavioral assessment. Large genomic rearrangement testing was performed by multiplex ligation-dependent probe amplification (MLPA) technique for all cases and Sanger sequencing was performed for MLPA negative cases. Large rearrangements were identified in approximately 1% in TSC1 and 14.3% in TSC2 genes. The present study observed the presence of duplications in two (2%) cases, both involving TSC2/PKD1 contiguous genes which to the best of our knowledge is reported for the first time. 8.1% of small variants were identified in the TSC1 gene and 85.7% in TSC2 gene, out of which 23 were novel variations and no variants were found in six (6.1%) cases. This study provides a representative picture of the distribution of variants in the TSC1 and TSC2 genes in Indian population along with the detailed assessment of neurological symptoms. This is the largest cohort study from India providing an overview of comprehensive clinical and molecular spectrum.


2009 ◽  
Vol 73 (2) ◽  
pp. 141-146 ◽  
Author(s):  
S. E. Camposano ◽  
E. Greenberg ◽  
D. J. Kwiatkowski ◽  
E. A. Thiele

2006 ◽  
Vol 28 (7) ◽  
pp. 440-446 ◽  
Author(s):  
Ji-Eun Choi ◽  
Jong-Hee Chae ◽  
Yong-Seung Hwang ◽  
Ki-Joong Kim

Sign in / Sign up

Export Citation Format

Share Document